Sandra Kim, MD
Pediatric Inflammatory Bowel Disease GastroenterologyPediatric Gastroenterology
Highlights
Age Groups Seen
- Child
- Adolescent
Languages
- English
Gender
FemaleAbout Sandra Kim
Biography
Sandra Kim, MD, a nationally recognized expert in pediatric and adolescent inflammatory bowel disease, is the Chief of Pediatric Gastroenterology, Hepatology and Nutrition.
Dr. Kim is a graduate of the University of Michigan’s Inteflex (Integrated Pre-medical/Medical) Program, earning bachelor’s degrees in Biomedical Sciences and Psychology as well as her medical degree.
Dr. Kim’s clinical and research interests focus on pediatric inflammatory bowel diseases, including adolescent transitioning and quality improvement in pediatric IBD, advocacy for care access, and the impact of the gastrointestinal microbiota in IBD. As a reflection of her dedication to her profession, Dr. Kim was awarded the 2011 and 2018 Rosenthal Awards and a 2020 Uniting to Care and Cure Award for her leadership in patient education and advocacy by the Crohn’s and Colitis Foundation.
She currently serves on the Board of Directors for Improve Care Now (ICN), a national pediatric IBD quality improvement network. She is the current co-chair of the DEI committee and a member of the Community Council for ICN. She is also a member of the Medical Advisory Board, Flying Horse Farms.
Dr. Kim has been an active member of the Crohn’s and Colitis Foundation over the past 25 years. She was a past chair for the Government Affairs and Pediatric Affairs committees for the Foundation’s National Scientific Advisory Committee (NSAC) and has remained involved in the Foundation - funded pediatric research network, PROKIIDS. She was on the Board of Directors for the Central Ohio chapter of the Foundation and recently completed her term as board president for the Western Pennsylvania/West Virginia chapter of the Foundation (2021-2022). She currently is a member of the Northern Ohio Chapter Board of Directors for the Foundation. She also joined the National Board of Trustees for the Crohn's and Colitis Foundation in 2023.
Read an article: Meet Sandra Kim, MD, Chair of Cleveland Clinic Children’s Department of Gastroenterology, Hepatology and Nutrition
Read an article: Managing Access and Making Advocacy Part of Your Pediatric Gastroenterology Practice
Listen to a podcast: IBD in Children
Locations
- Cleveland Clinic Children's Outpatient Center
- 8950 Euclid Avenue, Cleveland, OH 44106
- Get Directions
- Mercy Hospital Internal Medicine and Pediatrics, Stark
- 4575 Stephen Cir NW, Canton, OH 44718
- Get Directions
- Medina Medical Office Building
- 970 East Washington Street, Medina, OH 44256
- Get Directions
- Willoughby Hills Family Health Center, South Building
- 2570 Som Center Road, Willoughby Hills, OH 44094
- Get Directions
Education & Board Certifications
Education
- Fellowship: Baylor College of Medicine, 2000
- Residency: Baylor College of Medicine, 1997
- Medical Education: University of Michigan Medical School (Ann Arbor), 1994
- Undergraduate: University of Michigan, 1991
Board Certifications
- Pediatric Gastroenterology: American Board of Pediatrics, 2005
Awards
- Rosenthal Award (Crohn's and Colitis Foundation): 2011 and 2018
- Uniting to Care and Cure Award (Crohn's and Colitis Foundation): 2020
Professional Memberships
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2026-03-29, Dr. Kim has reported the financial relationships with the companies listed below.
Consulting and/or Speaking. Dr. Kim receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:
- Takeda Global Research & Development Center, Inc.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.